These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26197081)

  • 21. Dissolution enhancement and formulation of rapid-release lornoxicam mini-tablets.
    Tawfeek HM; Saleem IY; Roberts M
    J Pharm Sci; 2014 Aug; 103(8):2470-83. PubMed ID: 24995853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Innovation of novel sustained release compression-coated tablets for lornoxicam: formulation and in vitro investigations.
    Hamza Yel-S; Aburahma MH
    Drug Dev Ind Pharm; 2010 Mar; 36(3):337-49. PubMed ID: 19722915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of the drug release stability of different polymeric matrix tablets containing metronidazole.
    Szente V; Baska F; Zelkó R; Süvegh K
    J Pharm Biomed Anal; 2011 Mar; 54(4):730-4. PubMed ID: 21129883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Ibuprofen release preferences of medicinal products, the market share of excipients vement of a polymer].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2010; 40(4):19-26. PubMed ID: 21387838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formulation and evaluation of controlled release matrices of ketoprofen and influence of different co-excipients on the release mechanism.
    Wahab A; Khan GM; Akhlaq M; Khan NR; Hussain A; Khan MF; Khan H
    Pharmazie; 2011 Sep; 66(9):677-83. PubMed ID: 22026123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanistic Approach to Understanding the Influence of USP Apparatus I and II on Dissolution Kinetics of Tablets with Different Operating Release Mechanisms.
    Lu Z; Fassihi R
    AAPS PharmSciTech; 2017 Feb; 18(2):462-472. PubMed ID: 27106916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of Solubility Parameters of Ibuprofen and Ibuprofen Lysinate.
    Kitak T; Dumičić A; Planinšek O; Šibanc R; Srčič S
    Molecules; 2015 Dec; 20(12):21549-68. PubMed ID: 26633347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative structure property relationship modeling of excipient properties for prediction of formulation characteristics.
    Gaikwad VL; Bhatia NM; Desai SA; Bhatia MS
    Carbohydr Polym; 2016 Oct; 151():593-599. PubMed ID: 27474604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation of the potential for direct compaction of a fine ibuprofen powder dry-coated with magnesium stearate.
    Qu L; Zhou QT; Gengenbach T; Denman JA; Stewart PJ; Hapgood KP; Gamlen M; Morton DA
    Drug Dev Ind Pharm; 2015 May; 41(5):825-37. PubMed ID: 24738790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formulation development and optimization of Ibuprofen tablets by direct compression method.
    Bushra R; Shoaib MH; Aslam N; Hashmat D; Ur-Rehman M
    Pak J Pharm Sci; 2008 Apr; 21(2):113-20. PubMed ID: 18390440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accelerated degradation of ibuprofen in tablets.
    Cory WC; Harris C; Martinez S
    Pharm Dev Technol; 2010 Dec; 15(6):636-43. PubMed ID: 19941407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formulation and in-vitro evaluation of dextrin matrix tablet of Ibuprofen for colon specific drug delivery.
    Salunkhe KS; Kulkarni MV
    Pak J Pharm Sci; 2008 Jan; 21(1):17-20. PubMed ID: 18166513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of guar gum biopolymer in the prescription of tablets with sodium ibuprofen--quality tests and pharmaceutical availability in vitro.
    Berner-Strzelczyk A; Kołodziejska J; Zgoda MM
    Polim Med; 2006; 36(4):3-11. PubMed ID: 17402228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of face centred central composite design to optimise compression force and tablet diameter for the formulation of mechanically strong and fast disintegrating orodispersible tablets.
    Pabari RM; Ramtoola Z
    Int J Pharm; 2012 Jul; 430(1-2):18-25. PubMed ID: 22465631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amorphous magnesium carbonate nanoparticles with strong stabilizing capability for amorphous ibuprofen.
    Yang J; Alvebratt C; Lu X; Bergström CAS; Strømme M; Welch K
    Int J Pharm; 2018 Sep; 548(1):515-521. PubMed ID: 29981897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the Effect of Bioadhesive Polymers on Stability and Drug Release Kinetics of Biocompatible Hydrogels for Topical Application of Ibuprofen.
    Djekic L; Martinović M; Dobričić V; Čalija B; Medarević Đ; Primorac M
    J Pharm Sci; 2019 Mar; 108(3):1326-1333. PubMed ID: 30395827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parmacokinetic evaluation of ibuprofen controlled release matrix tablets using hydrophilic Eudragit® polymer and co-excipients.
    Bakhsh S; Khan GM; Menaa F; Khan BA
    Pak J Pharm Sci; 2015 Sep; 28(5):1745-55. PubMed ID: 26408874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced dissolution of ibuprofen using solid dispersion with poloxamer 407.
    Newa M; Bhandari KH; Oh DH; Kim YR; Sung JH; Kim JO; Woo JS; Choi HG; Yong CS
    Arch Pharm Res; 2008 Nov; 31(11):1497-507. PubMed ID: 19023548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of soluble and insoluble cyclodextrin polymers on drug release from hydroxypropyl methylcellulose tablets.
    Zugasti ME; Zornoza A; Goñi Mdel M; Isasi JR; Vélaz I; Martín C; Sánchez M; Martínez-Ohárriz MC
    Drug Dev Ind Pharm; 2009 Oct; 35(10):1264-70. PubMed ID: 19555243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined use of crystalline sodium salt and polymeric precipitation inhibitors to improve pharmacokinetic profile of ibuprofen through supersaturation.
    Terebetski JL; Cummings JJ; Fauty SE; Michniak-Kohn B
    AAPS PharmSciTech; 2014 Oct; 15(5):1334-44. PubMed ID: 24920524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.